Skip to content
Monday, March 27, 2023
Latest:
  • KYORIN and Eisai Enter Into License Agreement Concerning the Development and Marketing of Vibegron, a Treatment for Overactive Bladder, in Four ASEAN Countries
  • The Valens Company to Hold Conference Call to Discuss Financial Results for the First Quarter of 2021
  • AlumiFuel Reduces the Authorized Number of Shares
  • Seqirus Ready to Reinforce Canada’s Influenza Pandemic Preparedness Plans
  • FACT, Inc. Announces Patricia Trompeter as CEO
Biotech Research Report

Biotech Research Report

Know First, Act First

  • Covid-19
  • General
  • Cannabis
  • Fiscal & Financing
  • Pharmaceutical
  • Trending
AlumiFuel Reduces the Authorized Number of Shares
BIOTCHNO Featured 

AlumiFuel Reduces the Authorized Number of Shares

April 1, 2021August 4, 2021 RJ
Menarini Silicon Biosystems announces launch of CellMag(TM) product line offering affordable Gold Standard Circulating Tumor Cells capture
BIOTCHNO Featured 

Menarini Silicon Biosystems announces launch of CellMag(TM) product line offering affordable Gold Standard Circulating Tumor Cells capture

February 16, 2021May 24, 2021 Bachittar
InnerScope Hearing (INND)To Launch New Self-Fitting Direct-to-Consumer Hearing Aids with Remote Programming Feature
BIOTCHNO Trending 

InnerScope Hearing (INND)To Launch New Self-Fitting Direct-to-Consumer Hearing Aids with Remote Programming Feature

February 17, 2021April 15, 2021 Bachittar
Eisai Listed as a Global 100 Most Sustainable Corporation for the Fifth Time
BIOTCHNO Trending 

Eisai Listed as a Global 100 Most Sustainable Corporation for the Fifth Time

January 25, 2021April 15, 2021 vanessa
Taco Bell Indonesia Officially Opens Its First Restaurant in Jakarta
BIOTCHNO Trending 

Taco Bell Indonesia Officially Opens Its First Restaurant in Jakarta

December 19, 2020April 15, 2021 vanessa
BIOREM Announces Research Project with City of New York to Control Release of Bioaerosols from Waste Water Treatment Facilities
BIOTCHNO Trending 

BIOREM Announces Research Project with City of New York to Control Release of Bioaerosols from Waste Water Treatment Facilities

December 14, 2020April 15, 2021 vanessa

General

KYORIN and Eisai Enter Into License Agreement Concerning the Development and Marketing of Vibegron, a Treatment for Overactive Bladder, in Four ASEAN Countries
BIOTCHNO General 

KYORIN and Eisai Enter Into License Agreement Concerning the Development and Marketing of Vibegron, a Treatment for Overactive Bladder, in Four ASEAN Countries

July 19, 2021 Raza

TOKYO, Mar 31, 2021 – (JCN Newswire) – KYORIN Pharmaceutical Co., Ltd., a subsidiary of KYORIN Holdings, Inc., and Eisai

FACT, Inc. Announces Patricia Trompeter as CEO
BIOTCHNO General 

FACT, Inc. Announces Patricia Trompeter as CEO

March 22, 2021June 2, 2021 Raza
Sierra Oncology to Present at Three Upcoming Investor Conferences
BIOTCHNO General 

Sierra Oncology to Present at Three Upcoming Investor Conferences

March 3, 2021July 26, 2021 Raza
Mountain Valley MD Commencing Husbandry Animal Trials, Appoints Seasoned Doctor of Veterinary Medicine to Advisory Board
BIOTCHNO General 

Mountain Valley MD Commencing Husbandry Animal Trials, Appoints Seasoned Doctor of Veterinary Medicine to Advisory Board

March 1, 2021May 17, 2021 Raza
AmpliTech Group, Inc. Expands Board of Directors Announcing Second New Board Member
BIOTCHNO General 

AmpliTech Group, Inc. Expands Board of Directors Announcing Second New Board Member

February 28, 2021April 8, 2021 vanessa

Fiscal & Financing

The Valens Company to Hold Conference Call to Discuss Financial Results for the First Quarter of 2021
BIOTCHNO Fiscal & Financing 

The Valens Company to Hold Conference Call to Discuss Financial Results for the First Quarter of 2021

May 24, 2021June 7, 2021 Raza

  Canada NewsWire KELOWNA, BC , April 1, 2021 /CNW/ – The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the

Regor Therapeutics Announces Completion of $90 Million Series B Financing
BIOTCHNO Fiscal & Financing 

Regor Therapeutics Announces Completion of $90 Million Series B Financing

February 18, 2021April 8, 2021 Bachittar
The Valens Company to Hold Conference Call to Discuss Financial Results for the Fourth Quarter and Fiscal Year 2020
BIOTCHNO Fiscal & Financing 

The Valens Company to Hold Conference Call to Discuss Financial Results for the Fourth Quarter and Fiscal Year 2020

February 18, 2021April 15, 2021 Bachittar
Seegene posts unprecedented Q4 and 2020 FY results; writes history by joining trillion-won club
BIOTCHNO Fiscal & Financing 

Seegene posts unprecedented Q4 and 2020 FY results; writes history by joining trillion-won club

February 18, 2021April 15, 2021 Bachittar

Covid-19

Seqirus Ready to Reinforce Canada’s Influenza Pandemic Preparedness Plans
BIOTCHNO Covid-19 

Seqirus Ready to Reinforce Canada’s Influenza Pandemic Preparedness Plans

March 23, 2021April 15, 2021 Raza

  Canada NewsWire Health Canada’s Approval of FOCLIVIA ® (An Adjuvanted, Egg-Based A Strain H5N1 Pandemic Influenza Vaccine) Meets Key

CIRION and Providence Therapeutics Collaborate to Support COVID-19 Clinical Research
BIOTCHNO Covid-19 

CIRION and Providence Therapeutics Collaborate to Support COVID-19 Clinical Research

February 17, 2021April 15, 2021 Bachittar
The Top 3 Companies Racing to Create COVID-19 Vaccine
Covid-19 

The Top 3 Companies Racing to Create COVID-19 Vaccine

May 5, 2020April 8, 2021 Desiree Justice

Pharmaceutical

Biocytogen Subsidiary Eucure Biopharma Reports First Patient Enrolled in anti-CTLA4 Phase I Trial in China
BIOTCHNO Pharmaceutical 

Biocytogen Subsidiary Eucure Biopharma Reports First Patient Enrolled in anti-CTLA4 Phase I Trial in China

January 26, 2021April 15, 2021 vanessa

Canada NewsWire BOSTON and BEIJING, Jan. 26, 2021/CNW/ —Eucure Biopharma, a subsidiary of Biocytogen, announced the first patient enrollment for

Eisai to Present Abstracts on Lenvatinib at 2021 Gastrointestinal Cancers Symposium
BIOTCHNO Pharmaceutical 

Eisai to Present Abstracts on Lenvatinib at 2021 Gastrointestinal Cancers Symposium

January 11, 2021May 24, 2021 vanessa
Bronya Climate Shield Lab Results Indicate Fire Retardant Solution to OSB I-Joist Manufacturer
BIOTCHNO Pharmaceutical 

Bronya Climate Shield Lab Results Indicate Fire Retardant Solution to OSB I-Joist Manufacturer

January 7, 2021April 15, 2021 vanessa
Mountain Valley MD Files for Acceleration of Patent Examination for Solubilized Ivermectin
BIOTCHNO Pharmaceutical 

Mountain Valley MD Files for Acceleration of Patent Examination for Solubilized Ivermectin

December 24, 2020April 15, 2021 vanessa
Liminal BioSciences Announces First Subject Dosed in Phase 1 Multiple Ascending Dose Clinical Trial of Fezagepras
BIOTCHNO Pharmaceutical 

Liminal BioSciences Announces First Subject Dosed in Phase 1 Multiple Ascending Dose Clinical Trial of Fezagepras

December 15, 2020April 15, 2021 vanessa

Cannabis

SiliCycle signs a Letter of Intent with the Société Québécoise du Cannabis (SQDC)
BIOTCHNO Cannabis 

SiliCycle signs a Letter of Intent with the Société Québécoise du Cannabis (SQDC)

February 15, 2021April 14, 2021 Bachittar

SiliCycle signs a Letter of Intent with the Société Québécoise du Cannabis (SQDC) QUEBEC CITY , Dec. 15, 2020 /CNW

Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures
BIOTCHNO Cannabis 

Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures

November 18, 2020April 19, 2021 vanessa
  • Disclaimer
  • Privacy Policy
TD Media LLC dba Life Water Media
5826 New Territory Blvd. Unit #2144 Sugar Land, TX 77479